Life Science & Health Care
| Rank | Name | Agg. Deals Value | Clients Dimension | N. of Transactions | ![]() |
![]() |
![]() |
![]() |
![]() |
Last Quarter |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Latham & Watkins | 4100 | 50 | 4 | 96% | 98% | 98% | 95% | 98% | ![]() |
| 2 | McDermott Will & Emery | 745 | 1103 | 10 | 100% | 100% | 100% | 95% | 100% | ![]() |
| 3 | Allen & Overy | 515 | 1663 | 2 | 100% | 100% | 85% | 90% | 95% | ![]() |
| 4 | Hogan Lovells | 495 | 150 | 2 | 100% | 100% | 75% | 100% | 75% | ![]() |
| 5 | Baker McKenzie | 450 | 10000 | 1 | 90% | 95% | 95% | 95% | 95% | ![]() |
| 6 | King & Spalding | 375 | 250 | 2 | na | na | na | na | na | ![]() |
| 7 | Dechert | 175 | 788 | 2 | 100% | 100% | 100% | 100% | 100% | ![]() |
| 8 | Akilys | 150 | 75 | 1 | na | na | na | na | na | ![]() |
| 9 | Lerins & BCW | 120 | 150 | 2 | na | na | na | na | na | ![]() |
| 10 | De Gaulle Fleurance & Associes | 95 | 25 | 1 | na | na | na | na | na | ![]() |
| 11 | August & Debouzy | 65 | 250 | 1 | na | na | na | na | na | ![]() |
| 12 | Simmons & Simmons | 50 | 113 | 2 | 93% | 93% | 89% | 98% | 86% | ![]() |
| 13 | CMS Francis Lefebvre Avocats | 35 | 600 | 1 | 100% | 100% | 100% | 100% | 100% | ![]() |
| 14 | Osborne Clarke | 35 | 25 | 1 | 88% | 88% | 88% | 63% | 75% | ![]() |
| 15 | Dentons | 15 | 25 | 1 | 89% | 95% | 91% | 91% | 91% | ![]() |
| 16 | Mercure Avocats | 5 | 5000 | 1 | na | na | na | na | na | ![]() |
| 17 | Galien Affaires | 5 | 25 | 1 | na | na | na | na | na | ![]() |
| Rank | Name | Agg. Deals Value | Clients Dimension | N. of Transactions | ![]() |
![]() |
![]() |
![]() |
![]() |
Last Quarter |







